FDC
|
The Current P/B Ratio of FDC is 2.95.
| Share Price | ₹413.1 | Jan 05,2026 |
| Market Cap | ₹6,724.5 Cr | |
| Book Value | ₹2,281.1 Cr | Mar2025 - Consolidated Results |
| Price/Book | 2.95x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of FDC
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹6,724.5 Cr] as on Jan 05,2026
(/) Book Value [ ₹2,281.1 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 2.95x ]
Thus, for FDC , the investors are currently willing to pay '2.95 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of FDC !
The chart below summarizes the trend in P/B Ratio of FDC over the last five years.
Historical PB (Price/Book ) ratio chart of FDC
PB Ratio Performance Analysis for FDC
- FDC 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.65x.
- FDC 's operated at median p/b ratio of 2.78x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, FDC 's p/b ratio peaked in Mar2024 at 3.3x.
- FDC 's p/b ratio hit its five-year low in Mar2023 of 2.15x.
How does FDC 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| FDC | 2,281.08 | 2.95 | 6,724.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.75 | 415,121.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 11.28 | 168,918.0 |
| CIPLA LTD | 31,079.30 | 3.95 | 122,725.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 17.25 | 130,960.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.12 | 104,224.0 |
| MANKIND PHARMA LTD | 14,288.70 | 6.34 | 90,546.7 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 3.87 | 92,754.6 |
| LUPIN LTD | 17,119.50 | 5.55 | 94,931.9 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.15 | 70,123.1 |
| ABBOTT INDIA LTD | 4,204.27 | 14.24 | 59,874.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs FDC 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.15x |
| Max industry PB | 17.25x |
| Median industry PB | 5.55x |
| Average industry PB | 6.95x |
You may also like the below Video Courses